Christine Lindenboom | Investor Relations |
John Maraganore | Chief Executive Officer |
Yvonne Greenstreet | President & Chief Operating Officer |
Tolga Tanguler | Chief Commercial Officer |
Akshay Vaishnaw | President of R&D |
Jeff Poulton | Chief Financial Officer |
Pushkal Garg | Chief Medical officer |
Maury Raycroft | Jefferies |
Gena Wang | Barclays |
Tazeen Ahmad | Bank of America |
Ted Tenthoff | Piper Sandler |
Salveen Richter | Goldman Sachs |
Paul Matteis | Stifel |
Ritu Baral | Cowen |
Anupam Rama | JPMorgan |
Alethia Young | Cantor Fitzgerald |
Ladies and gentlemen, thank you for standing by and welcome to the Alnylam Pharmaceuticals Q3 2021 Earnings Call. [Operator Instructions] I would now like to turn the call over to the company.
You may begin.
Good morning. I'm Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications at Alnylam.